These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15320549)

  • 1. [Liposome-oriented transport of therapeutic drugs].
    Berezov TT; Iaglova NV; Dmitrieva TB; Zhirkov IuA; Chekhonin VP
    Vestn Ross Akad Med Nauk; 2004; (5):42-7. PubMed ID: 15320549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
    Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
    Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties of liposomes and their practical application].
    Halyts'ka SM; Nikol's'kyĭ IS
    Fiziol Zh (1994); 2008; 54(5):99-108. PubMed ID: 19058519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes as targetable drug carriers.
    Torchilin VP
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):65-115. PubMed ID: 3913530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity.
    Ishihara A; Yamauchi M; Tsuchiya T; Mimura Y; Tomoda Y; Katagiri A; Kamiya M; Nemoto H; Suzawa T; Yamasaki M
    J Biomater Sci Polym Ed; 2012; 23(16):2055-68. PubMed ID: 22054261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes for oral administration of drugs.
    Woodley JF
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):1-18. PubMed ID: 3913528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring liposomes for cancer drug delivery: from the bench to the clinic.
    Gabizon A
    Ann Biol Clin (Paris); 1993; 51(9):811-3. PubMed ID: 8166395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibility of the unification of directed drug transport as illustrated by liposome transport to target antigens].
    Trubetskoĭ VS; Berdichevskiĭ VR; Efremov EE; Torchilin VP; Smirnov VN
    Biull Eksp Biol Med; 1986 Sep; 102(9):305-7. PubMed ID: 3756331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodology and experimental design for the study of liposome-dependent drugs.
    Heath TD
    Methods Enzymol; 2005; 391():186-99. PubMed ID: 15721382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins as targeting agents for liposome encapsulated drugs.
    Toonen PA; Crommelin DJ
    Pharm Weekbl Sci; 1983 Dec; 5(6):269-80. PubMed ID: 6364035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.